Free Trial

West Pharmaceutical Services (WST) Stock Price, News & Analysis

$284.79
+7.63 (+2.75%)
(As of 07/26/2024 ET)
Today's Range
$275.49
$289.45
50-Day Range
$277.16
$342.78
52-Week Range
$265.00
$415.73
Volume
1.19 million shs
Average Volume
563,505 shs
Market Capitalization
$20.74 billion
P/E Ratio
37.57
Dividend Yield
0.28%
Price Target
$442.75

West Pharmaceutical Services MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
55.5% Upside
$442.75 Price Target
Short Interest
Healthy
1.71% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.53
Upright™ Environmental Score
News Sentiment
0.05mentions of West Pharmaceutical Services in the last 14 days
Based on 28 Articles This Week
Insider Trading
Selling Shares
$24.79 M Sold Last Quarter
Proj. Earnings Growth
17.91%
From $7.76 to $9.15 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.93 out of 5 stars

Medical Sector

21st out of 936 stocks

Surgical & Medical Instruments Industry

6th out of 101 stocks

WST stock logo

About West Pharmaceutical Services Stock (NYSE:WST)

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

WST Stock Price History

WST Stock News Headlines

West Pharmaceutical Services Inc. Q2 Profit Decreases, Misses Estimates
J.P. Morgan’s DIRE Warning
When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."
West Announces Second-Quarter 2024 Results
J.P. Morgan’s DIRE Warning
When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."
West to Host Second-Quarter 2024 Conference Call
See More Headlines
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/1 Dividend
4/23/2024
Dividend Payable
5/01/2024
Last Earnings
7/25/2024
Today
7/26/2024
Ex-Dividend for 8/7 Dividend
7/31/2024
Dividend Payable
8/07/2024
Next Earnings (Estimated)
10/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
CUSIP
95530610
Employees
10,600
Year Founded
1923

Price Target and Rating

Average Stock Price Target
$442.75
High Stock Price Target
$536.00
Low Stock Price Target
$375.00
Potential Upside/Downside
+55.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$593.40 million
Pretax Margin
22.79%

Debt

Sales & Book Value

Annual Sales
$2.93 billion
Cash Flow
$8.95 per share
Book Value
$39.31 per share

Miscellaneous

Free Float
72,457,000
Market Cap
$20.74 billion
Optionable
Optionable
Beta
1.00

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

WST Stock Analysis - Frequently Asked Questions

How have WST shares performed this year?

West Pharmaceutical Services' stock was trading at $352.12 on January 1st, 2024. Since then, WST stock has decreased by 19.1% and is now trading at $284.79.
View the best growth stocks for 2024 here
.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) announced its quarterly earnings results on Thursday, July, 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.77 by $0.25. The company's revenue was down 6.9% compared to the same quarter last year.

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

Does West Pharmaceutical Services have any subsidiaries?

West Pharmaceutical Services subsidiaries include these companies: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., The Tech Group Inc., Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), TGPR Holdings Limited, WD SG Pte. Ltd., and others.

Who are West Pharmaceutical Services' major shareholders?

Top institutional shareholders of West Pharmaceutical Services include Bank of New York Mellon Corp (4.49%), Riverbridge Partners LLC (0.67%), AustralianSuper Pty Ltd (0.38%) and Liontrust Investment Partners LLP (0.27%). Insiders that own company stock include Eric Mark Green, Thomas W Hofmann, Quintin J Lai, Annette F Favorite, Bernard Birkett, Cindy Reiss-Clark, Silji Abraham, Charles Witherspoon and Chad Winters.
View institutional ownership trends
.

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some other companies that West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V) and Alibaba Group (BABA).

This page (NYSE:WST) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners